Miliary brain metastases in lung cancer

Journal of Clinical Oncology

Volumn 28, Issue 34, 2010, Pages

  Ruppert, Anne Marie ^a   Stankoff, Bruno ^a   Lavolé, Armelle ^a   Gounant, Valérie ^a   Milleron, Bernard ^a   Seilhean, Danielle ^b  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; GADOLINIUM; METHYLPREDNISOLONE;

ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CASE REPORT; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATAL OUTCOME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS;

EID: 79951897073     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.0140     Document Type: Article

References (7)

1. Iguchi Y, Mano K, Goto Y, et al: Miliary brain metastases from adenocarcinoma of the lung: MR imaging findings with clinical and post-mortem histopathologic correlation. Neuroradiology 49:35-39, 2007 (Pubitemid 46062644)
2. Nemzek W, Poirier V, Salamat MS, et al: Carcinomatous encephalitis (miliary metastases): Lack of contrast enhancement. AJNR Am J Neuroradiol 14:540-542, 1993 (Pubitemid 23170531)
3. Paez JG, Jänne PA, Lee JC, et al: EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304:1497-1500, 2004 (Pubitemid 38720929)
4. Kim JE, Lee DH, Choi Y, et al: Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis. Lung Cancer 65:351-354, 2009
5. Ruppert AM, Beau-Faller M, Neuville A, et al: EGFR-TKI and lung adenocarcinoma with CNS relapse: Interest of molecular follow-up. Eur Respir J 33:436-440, 2009
6. Motoi N, Szoke J, Riely GJ, et al: Lung adenocarcinoma: Modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 32:810-827, 2008
7. Zhang X, Chang A: Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer. Int J Med Sci 5:209-217, 2008